DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rpz56x/diverticulitis) has announced the addition of the "Diverticulitis Global Clinical Trials Review, H1, 2015" report to their offering.
Diverticulitis Global Clinical Trials Review, H1, 2015 provides data on the Diverticulitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diverticulitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diverticulitis.
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Clinical Trial Overview of Top Companies
- Dr. Falk Pharma GmbH
- Shire Plc
- Pfizer Inc.
- SOFAR S.p.A.
- Actavis plc
Clinical Trial Overview of Top Institutes / Government
- Hallym University Medical Center
- McGill University Health Center
- Sahlgrenska University Hospital
- Academic Medical Center
- Agostino Gemelli University Polyclinic
- Akershus University Hospital
- Casa Sollievo della Sofferenza IRCCS
- Catholic University of the Sacred Heart
- Helsinki University Central Hospital
- Herlev Hospital
For more information visit http://www.researchandmarkets.com/research/rpz56x/diverticulitis